Cara Therapeutics and Vifor Pharma announce U.S. FDA approval of KORSUVA™ (difelikefalin) injection for the treatment of moderate-to-severe pruritus in hemodialysis patients

المصدر: Nasdaq GlobeNewswire / 23 أغسطس 2021 14:41:29   America/Chicago